Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Drug Development and Industrial Pharmacy|January 25, 2008
Melt extrusion and spray drying of carbamazepine and dipyridamole with polyvinylpyrrolidone/vinyl acetate copolymersJames E Patterson, Michael B James, Angus H Forster, et al.
International Journal of Pharmaceutics|December 19, 2006
Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball millingJames E Patterson, Michael B James, Angus H Forster, et al.
Journal of Pharmaceutical Sciences|July 30, 2005
The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compoundsJames E Patterson, Michael B James, Angus H Forster, et al.
Magnetic Resonance in Chemistry : MRC|August 2, 2005
Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMRDavid C Apperley, Angus H Forster, Romain Fournier, et al.
Vaccines|November 25, 2023
Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical TrialBen Baker, Imogen M Bermingham, Indika Leelasena, et al.
BMJ Global Health|October 12, 2023
Immunogenicity, safety, usability and acceptability of microarray patches for vaccination: a systematic review and meta-analysisMatthew N Berger, Ellen S Mowbray, Marian W A Farag, et al.
Plos One|July 30, 2021
Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trialAlexandra C I Depelsenaire, Katey Witham, Margaret Veitch, et al.
Vaccine|May 22, 2018
Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™)Germain J P Fernando, Julian Hickling, Cesar M Jayashi Flores, et al.
Plos Medicine|March 18, 2020
Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trialAngus H Forster, Katey Witham, Alexandra C I Depelsenaire, et al.
NPJ Vaccines|August 18, 2020
M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)Jamie-Lee S Mills, Cesar M Jayashi Flores, Simone Reynolds, et al.
Pageof 2